Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
Vext Science Inc (VEXTF) Q2 2024 Earnings Call Transcript Highlights: Revenue Stagnation and Strategic Moves in Ohio
Despite flat revenue and increased operating expenses, Vext Science Inc (VEXTF) sees promising growth in Ohio's retail sales and strategic positioning. Aug 21, 2024
GuruFocus Research Drug Manufacturers
Glenmark Pharmaceuticals Ltd (BOM:532296) Q1 2025 Earnings Call Transcript Highlights: Strong Growth in Europe and India Amid US Challenges
Glenmark Pharmaceuticals Ltd (BOM:532296) reports robust revenue growth and strategic advancements despite hurdles in the US market. Aug 19, 2024
GuruFocus Research Drug Manufacturers
Medicure Inc (MCUJF) Q2 2024 Earnings Call Transcript Highlights: Revenue Decline and Strategic Initiatives
Medicure Inc (MCUJF) reports a net loss amid increased R&D expenses and competition, while focusing on strategic growth and new drug development. Aug 16, 2024